1PH.F China Resources Medical Holdings Company Limited
- Market cap
- EUR 364M
- P/E
- 7.2x
- P/B
- 0.40x
- ROE
- 7.6%
- Dividend yield
- 6.07%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 1PH.F undervalued?
Graham number1PH.F trades 64.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
China Resources Medical Holdings Company Limited fundamental analysis
No fundamental analysis for China Resources Medical Holdings Company Limited yet.
China Resources Medical Holdings Company Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About China Resources Medical Holdings Company Limited
China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, hospital management, and other hospital-related services in the People's Republic of China. It operates through two segments Hospital and Other Business. The Hospital segment offers out-patient and in-patient business corresponding to self-owned hospitals. The Other Business segment offers operation management services, supply chain services, and other services to pa…
Full company profileChina Resources Medical Holdings Company Limited financial statements
China Resources Medical Holdings Company Limited annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1.53B | 1.88B | 2.06B | 2.12B | 2.75B | 4.45B | 5.62B | 10.1B | 9.85B | 9.18B |
| Gross Profit | 407M | 668M | 757M | 762M | 637M | 934M | 971M | 1.91B | 1.81B | 1.44B |
| Operating Income | 235M | 457M | 533M | 509M | 302M | 448M | 334M | 963M | 775M | 462M |
| EBITDA | - | 629M | 669M | 620M | 549M | 470M | 621M | 1.22B | 1.52B | 1.36B |
| Net Income | -1.51B | 421M | 431M | 391M | 310M | 418M | 139M | 258M | 566M | 496M |
| EPS | - | 0.32 | 0.33 | 0.30 | 0.24 | 0.32 | 0.11 | 0.20 | 0.45 | 0.39 |
| Balance Sheet | ||||||||||
| Total Assets | 6.45B | 6.91B | 7.32B | 7.87B | 8.96B | 10.5B | 11.1B | 13.7B | 13.3B | 12.9B |
| Total Liabilities | 1.09B | 1.31B | 1.61B | 1.73B | 2.62B | 3.62B | 4.11B | 6.64B | 5.82B | 5.03B |
| Shareholders' Equity | 5.24B | 5.48B | 5.59B | 5.90B | 6.11B | 6.45B | 6.46B | 5.81B | 6.21B | 6.55B |
| Cash & Short-term Investments | 1.07B | 877M | 1.52B | 2.01B | 2.70B | 2.32B | 2.98B | 1.28B | 977M | 940M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 224M | 460M | 334M | 366M | 644M | 710M | 627M | 1.20B | 1.27B | 1.36B |
| Capital Expenditure | 42.5M | 34.5M | 57.6M | 36.4M | 210M | 198M | 253M | 487M | 564M | 514M |
| Free Cash Flow | - | 425M | 277M | 330M | 426M | 483M | 374M | 708M | 707M | 844M |
| Ratios | ||||||||||
| ROE | -28.8% | 7.7% | 7.7% | 6.6% | 5.1% | 6.5% | 2.2% | 4.4% | 9.1% | 7.6% |
| ROA | -23.4% | 6.1% | 5.9% | 5.0% | 3.5% | 4.0% | 1.3% | 1.9% | 4.2% | 3.8% |
| Net Profit Margin | -98.3% | 22.4% | 20.9% | 18.5% | 11.3% | 9.4% | 2.5% | 2.5% | 5.7% | 5.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
China Resources Medical Holdings Company Limited dividends
- Dividend yield
- 6.07%
- Forward dividend
- 0.02 EUR
- Payout ratio
- 33.7%
- Ex-dividend date
- Sep 11, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 167M | 0.13 | 33.7% |
| 2024 | CNY 139M | 0.11 | 24.6% |
| 2023 | CNY 42.4M | 0.03 | 16.4% |
| 2022 | CNY 130M | 0.10 | 93.3% |
| 2021 | CNY 91.1M | 0.07 | 21.8% |
| 2020 | CNY 115M | 0.09 | 37.1% |
| 2019 | EUR 131M | 0.10 | 33.6% |
| 2018 | EUR 119M | 0.09 | 27.5% |
| 2017 | EUR 69.9M | 0.05 | 16.6% |
| 2016 | EUR 83.1M | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns China Resources Medical Holdings Company Limited
- Insiders 36.60%
- Institutions 10.14%
- Public & others 53.27%
- Shares outstanding 1.26B
- Free float 822M
China Resources Medical Holdings Company Limited company profile
- Company name
- China Resources Medical Holdings Company Limited
- Ticker
- 1PH.F
- ISIN
- KYG2133W1087
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 19,182
- Fiscal year end
- December
- Address
- Kunlun Center Office Building, Beijing, China, 100069
- Phone
- 86 10 5936 3990
- Website
- crmedical.hk
About China Resources Medical Holdings Company Limited
China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, hospital management, and other hospital-related services in the People's Republic of China. It operates through two segments Hospital and Other Business. The Hospital segment offers out-patient and in-patient business corresponding to self-owned hospitals. The Other Business segment offers operation management services, supply chain services, and other services to participating hospitals and IOT/OT hospitals. The company manages and operates third-party hospitals and clinics under the IOT model. In addition, it sells pharmaceuticals, medical devices, medical consumables, and non-medical supply. The company was formerly known as China Resources Phoenix Healthcare Holdings Company Limited and changed its name to China Resources Medical Holdings Company Limited in October 2018. The company was founded in 2007 and is headquartered in Beijing, the People's Republic of China.
China Resources Medical Holdings Company Limited management
8- Mr. Hai YuChairman · born 1968
- Mr. Chuang ZhangCEO & Executive Director · born 1978
- Mr. Xinchun WuExecutive Director & VP · born 1971
- Mr. Changjiu YuChief Financial Officer · born 1980
- Mr. Yuexing WangExecutive Director · born 1972
- Mr. Ming Fai Chung CPACompany Secretary · born 1979
- Mr. Bing ZhangVice President · born 1972
- Mr. Dayi GongVice President · born 1977